Knew Productions is a national award winning video production company based in Wrexham, UK. We have been delivering high impact video, photography and animation content to companies and organisations across the UK and internationally for twenty five years. Knew Productions has earned a strong reputation for excellence in video production within the Pharma Manufacturing and Biotech sectors. With over 20 years of experience filming in cleanroom environments and sterile production facilities, our team understands the unique demands of the industry. Our pharmaceutical clients include leading global names such as AstraZeneca, Ipsen, CSL Seqirus and Abbott Diabetes Care. Knew Productions use the power of video to help clients in the Life Sciences and Pharmaceutical sector to promote their products and services, communicate with prospective customers and train teams. Types of videos we produce include:- — Promotional — Manufacturing Process —Product Launch — Company Overview —Induction & Training — Case Studies — Internal Comms — Drug Product Preparation — Regulatory Audit, Validation & Qualification
Klaster LifeScience Kraków Foundation
Klaster Life Science Kraków – Driving Innovation at the Intersection of Science, Business, and Healthcare The Klaster Life Science Kraków is a thriving, cross-sectoral ecosystem that connects over 200 science and business organisations across biotech, medtech, diagnostics, pharma, healthcare, research, and public administration. Coordinated by the Klaster LifeScience Kraków Foundation, it catalyses innovation, strategic collaboration, and international business development in the heart of Central Europe. Located in Małopolska, one of Poland’s most innovation-driven regions, the Network provides access to cutting-edge R&D, top academic institutions, EU-funded infrastructure, and a pool of highly skilled professionals. It is an ideal entry point for foreign partners and investors seeking scalable solutions, co-development opportunities, and regional market expansion. The Network actively supports internationalisation through matchmaking missions, project consortia, and access to public-private initiatives aligned with the European Union’s Smart Specialisation Strategy. Its members benefit from structured innovation support, access to funding, and connections to policymakers and key opinion leaders. Małopolska, recognised as a European entrepreneurial region, offers competitive operational costs, investment incentives, and a stable regulatory environment. Kraków’s position as a life science hub makes it a springboard for ventures targeting Central and Eastern Europe. Discover Klaster Life Science Kraków at BIO International Convention—partner with us and be part of Europe’s next frontier in life science innovation and investment. Life Science Open Space – Where Collaboration Fuels Innovation The Life Science Open Space is the flagship collaboration platform of the Life Science Kraków Cluster—a unique event and year-round program dedicated to turning ideas into impactful solutions in health, quality of life, and sustainable development. Hosted annually in Kraków, Poland, and supported by a vibrant ecosystem of innovators, the platform connects a broad spectrum of stakeholders—from science, business, medicine, and public sectors—who share a common goal: to collaborate, not compete. At its core, Life Science Open Space (www.LSOS.info) redefines the traditional conference format. It is not a marketplace of products or services but a space for co-creation—where challenges are openly shared, projects are formed, and partnerships are forged. Through collaboration proposals, participants are invited to engage in meaningful conversations, contribute their expertise, and jointly develop solutions. LSOS offers a carefully curated program of thematic sessions, co-creation presentations, expert panels, and matchmaking opportunities. Its open formula encourages honest dialogue and transparency, empowering attendees to build multi-disciplinary project teams, apply for joint funding, and scale innovations faster. Whether you’re a researcher seeking industrial partners, a startup looking for clinical validation, or a corporation scouting disruptive tech, LSOS provides the right environment to accelerate ideas into action. The platform also serves as a gateway to long-term community engagement through its online extension (www.lifescienceopenspace.com), which fosters year-round collaboration. It supports ecosystem growth by linking innovation seekers with solution providers across Poland and Europe. By participating in Life Science Open Space, you gain more than contacts—you gain co-creators, champions, and access to a trusted network that values openness, trust, and shared impact. Visit www.lsos.info and www.lifescienceopenspace.com to discover how collaboration becomes a strategy in the Life Science Kraków cluster.
IQVIA BRASIL
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and accelerate innovations. With approximately 88,000 employees in over 100 countries, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. Learn more at www.iqvia.com.
Indian Immunologicals Ltd
Indian Immunologicals Limited (IIL) is a leading vaccine manufacturer. We are a fully integrated player, conceptualizing and executing the products journey from bench at the R&D lab to its sale at the clinic. Our journey of forty years of saving lives through developing, scaling up and executing huge scale manufacturing projects has honed our skills of projects management, efficient execution, excellence in regulatory compliance and at the same time offering agility, competitiveness, and trusted result-oriented approach. IIL has a strong portfolio of products, both in the human health segment and animal health segment. We have been spearheading the One Health initiative, globally. As a result of our presence in these two segments, we recognized both, the inter-dependence, and inter-linkages of the two segments and as a result have been spearheading the One Health initiative since a long time. IIL had its humble beginnings as a veterinary vaccine manufacturing company in the year 1982. Since then, it has scaled up to become one of the major vaccines manufacturer of the country and the region. We ventured into manufacturing human vaccines by 1998 on specific request by the Government of India. As a result, IIL became the second company in the world and first in India to launch purified vero cell rabies vaccine (PVRV) and markets it under the brand – Abhayrab. It is today by far the largest manufacturer of human rabies vaccine in the world. IIL today has a portfolio of eight commercial human vaccines and has a pipeline of nine new vaccine candidates. We have a huge pipeline of vaccine for Animal Health segment. We are one of the leading manufacturers of Pet Vaccines. IIL has four world class manufacturing facilities spread across India and New Zealand. IIL collaborates with several leading pharma/vaccines companies within India and outside for manufacturing and research collaborations. Our capabilities and experience in handling projects across varied platforms technologies, across varied scales (small to very high) enable us to offer both flexibility and confidence to our partners for a smooth execution. We solicit cooperation proposals to build synergistic relationships. | Indian Immunologicals Limited (IIL) is a leading vaccine manufacturer. We are a fully integrated player that conceptualizes and executes the products journey from bench at the R&D lab to its use at the clinic. Our journey of forty years of saving lives through developing, scaling up and executing huge scale manufacturing projects has honed our skills of projects management, efficient execution, excellence in regulatory compliance and at the same time offering agility, competitiveness, and trusted result-oriented approach. IIL has a strong portfolio of products, both in the human health segment and animal health segment. We have been spearheading the One Health initiative, globally. As a result of our presence in the two segments, we recognized both, the interdependence, and interlinkages of the two segments and as a result have been spearheading the One Health initiative for a long time. IIL has its humble beginnings as a veterinary vaccine manufacturing company in the year 1982. Since then, it has scaled up to become one of the major vaccines manufacturers of the region. After starting off an animal vaccine manufacturer, we started manufacturing human vaccines in 1998 on a specific request by the Government of India. As a result, IIL became the second company in the world and first in India to launch purified vero cell rabies vaccine (PVRV) and markets it under the brand – Abhayrab. It is today by far the largest manufacturer of human rabies vaccine in the world. IIL today has a portfolio of eight commercial human vaccines and has a pipeline of five new vaccine candidates. We are currently serving and touching lives in more than fifty (60) countries by exporting both our animal health and human health products. We have four world class manufacturing units spear across India and New Zealand. IIL, through its state-of-the-art facilities, collaborates with several leading pharma/vaccines companies within India and outside.
Hickey & Associates
Hickey is a family of interconnected organizations supporting businesses, economic development organizations, and governments as they navigate their location strategy, financing, incentives, and business promotion and attraction. Hickey & Associates is the global leader in site selection, location strategy, credits & incentives advisory, and labor analytics consulting. We assist life sciences businesses with the critical data capture and strategic vision to navigate a global real estate footprint. Active projects in the Americas, Asia, Europe, Australia, Middle East, and Africa all utilize our state-of-the-art tools, techniques, and knowledge. Hickey Global Economic Development Consulting (Hickey Global) is a full-service economic development consulting firm supporting private, public, and non-profit economic development organizations around the world. We create custom solutions to help communities prosper by identifying opportunities for investment and job growth.
GlobalData
GlobalData has decades of experience in being the trusted, gold standard intelligence provider to leading Pharmaceutical brands, manufacturers, and suppliers, helping them to make faster, more informed decisions. | GlobalData is a data and analytics company providing the Life Science Community with Market and Competitive Intelligence. GlobalData serves over 4,000 world’s largest companies with over 600 healthcare analysts by gaining insights into competitors, evaluating market opportunities, and provide strategic opinions in the Pharma/Biotech, CMO/CDMO, CRO, Medical Device/Medtech and Consumer Health industries. From research and development, clinical trials, business developments to investment due diligence, our clients can make better business decisions on our fully integrated one-stop intelligence center platform. | GlobalData’s Construction portfolio offers insights across the entire global construction market, from market-sizing, companies, construction innovations, risks, regulatory developments, M&A, and financial transactions, to projects and project contacts. Our connected Construction Intelligence offers the most comprehensive coverage of construction projects available, tracking new construction projects totaling over US$70tn globally from announcement to completion, by sector, stage, scope, and more. Our industry leading portfolio of brands include Cranes Today, Tunnels & Tunnelling, and World Construction Network amongst others, and have informed the construction landscape since 1969.
GLG
GLG provides our clients the insight they need to confidently expand their business, make informed strategic decisions, effectively develop products, and go to market with confidence. Our trusted market research team helps you identify the research approach that will provide the clarity you need to meet your most important business objectives. | GLG connects pharmaceutical, healthcare services, and biotechnology companies to healthcare providers and professionals, regulatory experts, key opinion leaders, and the entire life sciences ecosystem. Insights from these experts help inform your product development and go-to-market strategies, helping you stay patient-focused at every step.
German Pavilion
1) Presented by: Federal Ministry for Economic Affairs and Energy (BMWE) internet: www.bundeswirtschaftsministerium.de 2) in Cooperation with: AUMA_Association of the German Trade Fair Industry internet: www.auma-messen.de 3) supported by: SPECTARIS – German industry association for Optics, Photonics, Analytical and Medical Technologies internet: www.spectaris.de 4) organized by: IEC Inter Expo Consult GmbH internet: www.iecberlin.de Germany participates with a “German Pavilion” offering a professional brokerage service to help to establish contacts with German companies and comprehensive information on Germany as an important business location. | Welcome to the German Pavilion. | Germany participates with a “German Pavilion” offering a professional brokerage service to help to establish contacts with German companies and comprehensive information on Germany as an important business location. | Germany participates with a company joint presentation which is presented by the Federal Ministry for Economic Affairs and Energy and supported by AUMA – Association of the German Trade Fair Industry and organized by Hannover Fairs International GmbH. | Brands:Emanuel Wilfer e. K., WITTNER GmbH & Co. KG, Karl Höfner GmbH & Co. KG, Paesold, Doerfler Bows, Schlagwerk GmbH, Instruments of Things, Geller Ebonit, Traps Drums Profi Sound | Bundesverband der deutschen Musikinstrumentenhersteller e.V.Brunnenstr.3165191 WiesbadenDeutschland Tel +49 611 954588-6Fax +49 611 954588-5Mobil +49 172 683750-0 | Official German Pavilion sponsored from the Ministry of Economics – Organized from IEC Berlin. Exhibitors 2026: Klangio Wilde+Spieth Roderich Paesold Höfner Brandenburg Labs Streamsoft Fraunhofer IDMT Institutsteil Verband Deutscher Tonmeister e. V. Georg Neumann GmbH Sennheiser Research and Development GmbH GEWA music GmbH Schlagwerk GmbH | Welcome to the German Pavilion! We warmly invite you to visit more than 30 exhibitors from Germany and discover their latest technologies, innovative solutions, and high-quality services. Take the opportunity to connect with industry experts and explore new business possibilities in a dynamic international environment. In addition, learn more about Germany as an attractive travel destination, offering a unique combination of culture, innovation, and hospitality. We look forward to welcoming you! | German Pavilion Booth No. 3826Federal Ministry for Economic Affairs and Energy (BMWE)in Cooperation with AUMA Association of the German Trade Fair IndustryInternet: The Battery Show North America 2025 / German PavilionGermany participates with a “German Pavilion” offering a professional brokerage service to help to establish contacts with German companies and comprehensive information on Germany as an important business location.
GeneQuantum Healthcare (Suzhou) Co.,Ltd
GeneQuantum (GQ) is a leading ADC biotech company with proprietary one-enzyme-one-reaction bioconjugation technology and highly stable hydrophilic linkers that can generate the next generation of ADC molecules with: 1) homogeneous and site-specific conjugation for DAR2, DAR4, DAR6 and DAR8; 2) super stability with DAR value remains stable for >7 days in circulation; 3) 100% removal of ADCC without antibody engineering. We have established a highly differentiated ADC pipeline with 3 clinical stage programs, one pre-clinical program (out-licensed to Pyramid/Biohaven), and multiple programs including dual-payload ADC and radionuclide drug conjugates (RDC). Our ADC technology can be pluged & played into the current antibody manufacturing facility – no need for building dedicated ADC facilities. A number of global leading CDMOs including Wuxi XDC have licensed our technology and already completed GMP production for clinical supply. | GeneQuantum (GQ) has developed a strong pipeline of next-gen of ADCs with wider therapeutic window & higher affordability with its proprietary One-Enzyme-One-Reaction bioconjugation technology (DAR2/4/6/8, super stable both in circulation and in storage in liquid form, ADCC depletion w/o Fc engineering, ADCs manufactured in mAb facility, dual payload pADCs, RDCs, and AOCs, etc.) with 5 clinical programs including 1 currently in registration trial in China. Strategic Collaborations: Biohaven: out licensed the global right of GQ1011 (anti-FGFR3 ADC ) Biohaven: long term strategic collaboration to develop ADCs on multi-targets AimedBio: long term strategic collaboration to develop ADCs on multi-targets Pyramid: out licensed the ex-China right of GQ1010 (anti-TROP2 ADC) 2024 BD Milestone: executed 4 out-licensing deals in 2024 with total US$13B Bio$, the most # of deals done by a Chinese ADC in 2024
Gador S.A.
Gador is a leading Argentine pharmaceutical company. For the last 82 years, its mission has been to investigate, develop, manufacture and commercialize the best quality medicines for every patient at affordable prices. Gador continuously invests in product technology and quality control, according to international standards and maintains a large updated portfolio of pharmaceutical products. Our company is currently focused on biopharmaceutics as a source of innovation and generation of new therapeutic resources for its territory, which is expanded throughout Latin America. Gador has a longstanding experience in the commercialization of special products, either own products or licenses from world renowned companies, such as Gilead Sciences Ltd, Astellas Pharma, Eli Lilly, Coherus, Viatris, MSD, Novartis, Cipla, among others. As a leader company in the market, Gador has undertaken an ambitious program in this area, which involves: Licenses of new products approved or at their last clinical development stage Commercialization of a new-generation biosimilar Development and commercialization of new biopharmaceuticals with focus in special products and rare disease | Gador is a leading Argentine pharmaceutical company. For the last 82 years, its mission has been to investigate, develop, manufacture and commercialize the best quality medicines for every patient at affordable prices. Gador continuously invests in product technology and quality control, according to international standards and maintains a large updated portfolio of pharmaceutical products. Our company is currently focused on biopharmaceutics as a source of innovation and generation of new therapeutic resources for its territory, which is expanded throughout Latin America. Gador has a longstanding experience in the commercialization of special products, either own products or licenses from world renowned companies, such as Gilead Sciences Ltd, Astellas Pharma, Eli Lilly, Coherus, Sifi, Recordati, Boehringer, Viatris, MSD, Novartis, among others. As a leader company in the market, Gador has undertaken an ambitious program in this area, which involves: Licenses of new products approved or at their last clinical development stage Commercialization of a new-generation biosimilar Development and commercialization of new biopharmaceuticals with focus in special products and rare disease | Gador is a leading pharmaceutical Company that investigate, develop, manufacture and commercialize medicinal products for human use. It is based in Argentina since 1940 and today covers the whole Latin America through own affiliates or a net of exclusive distributors. Gador continuously invests in product technology, quality control and new facilities development, according to international standards and approvals such as FDA, EMA, KFDA, COFEPRIS, TGA, among others.. Our company is currently focused on innovative therapies and products, such as biopharmaceutics, oligonucleotides and gene therapies as a source of generation of new therapeutic resources for its territory, which is expanded throughout Latin America. Gador has a long-standing experience in the commercialization of special and primary care products, either own products or licenses from world renowned companies, such as Gilead Sciences, Astellas, MSD, Boehringer Ingelheim, Recordati, Viatris, Sifi, Galderma, Besins, among others. As a leader company in the market, Gador has undertaken an ambitious program in this area, which involves: Licenses of new products approved or at their last clinical development stage Commercialization of a new-generation biosimilar Development and commercialization of new biopharmaceuticals with focus in special products and rare disease In addition, Gador´s main shareholders have created a new development company: Qualix Dot (Design on Therapies). Qualix DoT is the research and development pharmaceutical company of Qualix Ventures.The purpose of Qualix DoT is to explore, drive, and collaborate in world-class innovative projects that come from academic or industrial initiatives by mainly repurposing known compounds for new indications. Qualix DoT adopts a collaborative business model whereby it works in partnership with academic, industrial and patients’ organizations. Biopharmaceuticals – rare disease – oncology – biosimilars – CAR T – Oligonucleotides y Repurposing